Viewing nowLosartan 100 mg (Losartan Potassium)
Losartan Potassium 100mg
Tablet · Prescription medication
Yuhan Corporation

MFDS item code 200701872 · Notified 2007.02.12 · Insurance code 642100310
Treatment of hypertension and nephropathy in patients with type 2 diabetes mellitus accompanied by hypertension
This medicine is used to effectively control blood pressure in patients with hypertension. It is particularly effective in treating patients with kidney disease among those suffering from type 2 diabetes. Therefore, it is important to use this medication for the prevention and management of complications related to hypertension. This medication helps to maintain stable blood pressure and reduce cardiovascular risks. It contributes to improving the patient's health condition and enhancing overall quality of life. It is used to treat hypertension and related kidney disease.
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is observed 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be administered orally in two divided doses per day, or the dose may be increased to up to 100 mg once daily if necessary. If blood pressure is not controlled with this medicine alone, it may be administered in combination with another antihypertensive medicine (e.g., a low-dose diuretic). An additive effect has been observed when administered in combination with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. Depending on blood pressure, the dose may be increased to up to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered in combination with insulin and commonly used blood glucose-lowering medicines (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations Elderly patients No adjustment of the initial dose is necessary in elderly patients aged 75 years or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Patients with renal impairment Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. Patients with reduced effective intravascular volume For patients who may have reduced effective intravascular volume (e.g., patients receiving diuretic treatment), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use section). Patients with hepatic impairment A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents 6 years of age and older: Patients weighing 20 kg or more and less than 50 kg who are able to swallow tablets — The recommended dose is 25 mg of this drug once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents 6 years of age and older: Patients weighing 50 kg or more — The usual recommended dose is 50 mg of this drug once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. This drug is not recommended for children under 6 years of age, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.
This medication can cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Patients with severely impaired liver or kidney function, hereditary angioedema, and those with issues related to lactose in this medication should not use it. Elderly patients, those with hyperkalemia, and patients with slightly impaired liver function should use this medication cautiously and beware of excessive drops in blood pressure. While taking this medication, side effects such as dizziness, muscle cramps, back pain, cough, and indigestion may occur, so patients should monitor their physical condition closely. If symptoms of angioedema or severe allergic reactions appear, the medication should be discontinued immediately and medical consultation sought. This medication can interact with other drugs, so it is advisable to consult a doctor when taken with potassium supplements, certain diuretics, or non-steroidal anti-inflammatory drugs (NSAIDs). Pregnant or breastfeeding women are advised not to take this medication, and in unavoidable cases, should consult a professional and discontinue breastfeeding. Children, especially those under 6 years old or those with severely impaired kidney function, should not use this medication. In cases of overdose, hypotension and arrhythmias may occur, necessitating immediate treatment, and this medication is not removed by hemodialysis. During treatment, patients should regularly monitor blood pressure, kidney function, and serum electrolyte levels for any abnormalities. Caution is needed when performing tasks requiring concentration, such as driving or working at heights, during treatment with this medication. Keep this medication out of reach of children and do not transfer it to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to prevent exposure to air or moisture. It is best to maintain storage temperatures between 1 and 30 degrees Celsius. Proper storage will help prolong the effectiveness and safety of the medication.
White oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 100mg
Tablet · Prescription medication
Yuhan Corporation

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.